chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: Joint pain; Arm swelled up from the shoulder to the elbow and around to the inner arm; It is hot, hard, swollen, and extremely painful; from the shoulder to the elbow and around to the inner arm. It was hot, hard, swollen, and extremely painful.; Arm swelled up from the shoulder to the elbow and around to the inner arm; Headache; Low grade fever of 100.2F; This is a spontaneous report from a contactable other healthcare professional. A 43-year-old female patient received second dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK4176; expiry date: unknown) via an unspecified route of administration in the left arm on 08Jan2021 on 15:00, at a single dose, for COVID-19 immunization. Medical history included gastrooesophageal reflux disease (GERD), bariatric surgery, seasonal allergies, and known allergies to bee stings, flu vaccine, and monosodium glutamate (MSG). Concomitant medications included famotidine (PEPCID) and cetirizine hydrochloride (ZYRTEC), and multivitamins. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EH9899; expiry date: unknown) on 17Dec2020, at 01:00 PM, in the left arm, for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital.  On 09Jan2021, at 14: 30, the patient's arm swelled up from the shoulder to the elbow and around to the inner arm. It was hot, hard, swollen, and extremely painful. She also had joint pain, headache, and low-grade fever of 100.2 Fahrenheit (F). The patient did not received therapy for the events. Outcome of the events was not recovered. The patient has not been tested for COVID-19 since vaccination.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dizziness, Muscular weakness, Nausea, Pain in extremity
Clinical narrative: I started running a mild fever the next day and I still have a fever today; feel lightheaded; weak; feeling nausea; my legs were weak; my throat got tight; This is a spontaneous report from a contactable HCP. This 44-year-old female (patient) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231) at left arm at single dose for COVID-19 immunization on 08Jan2021 05:30 PM. Relevant medical history included osteoporosis and menopause. Known allergies included: soy, dairy, all nuts, sunflower, cottonwood, lentils, chickpeas, Vit E, cephalexin, Amoxicillin, sulfa, Bactrim, lisinopril , estrogen, moxifloxacin, Pseudoephedrine, paroxetine, trimethoprim, doxycycline, azithromycin, cipro, clindamycin, colestipol. The patient was not pregnant.   Relevant concomitant drug included Vit D, calcium, ibuprofen. Five minutes after receiving the vaccine, her throat got tight then she started to feel lightheaded and her legs were weak. She notified the staff there who offered her Benadryl but she declined. She began feeling nausea about an hour later and she felt lightheaded and weak for about 4 hours. She started running a mild fever the next day and she still had a fever on 12Jan2021. The patient did not receive other vaccine in four weeks. The outcome of events was recovering. No treatment was received. The patient was not COVID infected prior vaccination. The patient did not have COVID tested post vaccination.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Throat tightness
Clinical narrative: I started running a mild fever the next day and I still have a fever today; feel lightheaded; weak; feeling nausea; my legs were weak; my throat got tight; This is a spontaneous report from a contactable HCP. This 44-year-old female (patient) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231) at left arm at single dose for COVID-19 immunization on 08Jan2021 05:30 PM. Relevant medical history included osteoporosis and menopause. Known allergies included: soy, dairy, all nuts, sunflower, cottonwood, lentils, chickpeas, Vit E, cephalexin, Amoxicillin, sulfa, Bactrim, lisinopril , estrogen, moxifloxacin, Pseudoephedrine, paroxetine, trimethoprim, doxycycline, azithromycin, cipro, clindamycin, colestipol. The patient was not pregnant.   Relevant concomitant drug included Vit D, calcium, ibuprofen. Five minutes after receiving the vaccine, her throat got tight then she started to feel lightheaded and her legs were weak. She notified the staff there who offered her Benadryl but she declined. She began feeling nausea about an hour later and she felt lightheaded and weak for about 4 hours. She started running a mild fever the next day and she still had a fever on 12Jan2021. The patient did not receive other vaccine in four weeks. The outcome of events was recovering. No treatment was received. The patient was not COVID infected prior vaccination. The patient did not have COVID tested post vaccination.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dizziness, Muscular weakness, Nausea, Pyrexia
Clinical narrative: I started running a mild fever the next day and I still have a fever today; feel lightheaded; weak; feeling nausea; my legs were weak; my throat got tight; This is a spontaneous report from a contactable HCP. This 44-year-old female (patient) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231) at left arm at single dose for COVID-19 immunization on 08Jan2021 05:30 PM. Relevant medical history included osteoporosis and menopause. Known allergies included: soy, dairy, all nuts, sunflower, cottonwood, lentils, chickpeas, Vit E, cephalexin, Amoxicillin, sulfa, Bactrim, lisinopril , estrogen, moxifloxacin, Pseudoephedrine, paroxetine, trimethoprim, doxycycline, azithromycin, cipro, clindamycin, colestipol. The patient was not pregnant.   Relevant concomitant drug included Vit D, calcium, ibuprofen. Five minutes after receiving the vaccine, her throat got tight then she started to feel lightheaded and her legs were weak. She notified the staff there who offered her Benadryl but she declined. She began feeling nausea about an hour later and she felt lightheaded and weak for about 4 hours. She started running a mild fever the next day and she still had a fever on 12Jan2021. The patient did not receive other vaccine in four weeks. The outcome of events was recovering. No treatment was received. The patient was not COVID infected prior vaccination. The patient did not have COVID tested post vaccination.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat tightness
Clinical narrative: I started running a mild fever the next day and I still have a fever today; feel lightheaded; weak; feeling nausea; my legs were weak; my throat got tight; This is a spontaneous report from a contactable HCP. This 44-year-old female (patient) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231) at left arm at single dose for COVID-19 immunization on 08Jan2021 05:30 PM. Relevant medical history included osteoporosis and menopause. Known allergies included: soy, dairy, all nuts, sunflower, cottonwood, lentils, chickpeas, Vit E, cephalexin, Amoxicillin, sulfa, Bactrim, lisinopril , estrogen, moxifloxacin, Pseudoephedrine, paroxetine, trimethoprim, doxycycline, azithromycin, cipro, clindamycin, colestipol. The patient was not pregnant.   Relevant concomitant drug included Vit D, calcium, ibuprofen. Five minutes after receiving the vaccine, her throat got tight then she started to feel lightheaded and her legs were weak. She notified the staff there who offered her Benadryl but she declined. She began feeling nausea about an hour later and she felt lightheaded and weak for about 4 hours. She started running a mild fever the next day and she still had a fever on 12Jan2021. The patient did not receive other vaccine in four weeks. The outcome of events was recovering. No treatment was received. The patient was not COVID infected prior vaccination. The patient did not have COVID tested post vaccination.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeding disorder, Lymphadenopathy, Pain in jaw
Clinical narrative: I developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes.; I developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes.; I developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes.; I developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes.; I developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes.; This is a spontaneous report from a contactable other healthcare professional (patient) reported that a 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELO146), via an unspecified route of administration on right arm on 23Dec2020 12:00 at a single dose for covid-19 immunisation. Medical history included hypertension, osteopenia, hypercholesterolaemia and migraine; all from an unknown date. Patient is not pregnant. The patient had her second dose of pneumonia vaccine on 01Dec2020 that was administered on her right arm for immunization. Concomitant medications included calcium, alendronate sodium (FOSAMAX), losartan, meloxicam and simvastatin; all were taken from an unspecified date for an unspecified indication. The patient previously took naproxen sodium (NAPROSYN) and experienced drug allergy. On 28Dec2020 12:00, the patient developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes. The patient did not received any treatment for the reported events. The patient underwent lab tests and procedures which included covid-19: negative on 28Dec2020, on 30Dec2020, on 04Jan2021 and on 08Jan2021 (nasal swab) while on 11Jan2021 (nasal swab) had pending result. The outcome of the events was recovered.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Facial pain, Lymph node pain, Lymphadenopathy, Pain in jaw
Clinical narrative: I developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes.; I developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes.; I developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes.; I developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes.; I developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes.; This is a spontaneous report from a contactable other healthcare professional (patient) reported that a 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELO146), via an unspecified route of administration on right arm on 23Dec2020 12:00 at a single dose for covid-19 immunisation. Medical history included hypertension, osteopenia, hypercholesterolaemia and migraine; all from an unknown date. Patient is not pregnant. The patient had her second dose of pneumonia vaccine on 01Dec2020 that was administered on her right arm for immunization. Concomitant medications included calcium, alendronate sodium (FOSAMAX), losartan, meloxicam and simvastatin; all were taken from an unspecified date for an unspecified indication. The patient previously took naproxen sodium (NAPROSYN) and experienced drug allergy. On 28Dec2020 12:00, the patient developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes. The patient did not received any treatment for the reported events. The patient underwent lab tests and procedures which included covid-19: negative on 28Dec2020, on 30Dec2020, on 04Jan2021 and on 08Jan2021 (nasal swab) while on 11Jan2021 (nasal swab) had pending result. The outcome of the events was recovered.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test, Swelling face
Clinical narrative: I developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes.; I developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes.; I developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes.; I developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes.; I developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes.; This is a spontaneous report from a contactable other healthcare professional (patient) reported that a 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELO146), via an unspecified route of administration on right arm on 23Dec2020 12:00 at a single dose for covid-19 immunisation. Medical history included hypertension, osteopenia, hypercholesterolaemia and migraine; all from an unknown date. Patient is not pregnant. The patient had her second dose of pneumonia vaccine on 01Dec2020 that was administered on her right arm for immunization. Concomitant medications included calcium, alendronate sodium (FOSAMAX), losartan, meloxicam and simvastatin; all were taken from an unspecified date for an unspecified indication. The patient previously took naproxen sodium (NAPROSYN) and experienced drug allergy. On 28Dec2020 12:00, the patient developed jaw pain and intense pain chewing on the right side for 48 hours, plus swelling and pain in the right cheek and right neck lymph nodes. The patient did not received any treatment for the reported events. The patient underwent lab tests and procedures which included covid-19: negative on 28Dec2020, on 30Dec2020, on 04Jan2021 and on 08Jan2021 (nasal swab) while on 11Jan2021 (nasal swab) had pending result. The outcome of the events was recovered.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Body temperature increased, Chills, Diarrhoea, Pain
Clinical narrative: Severe body aches; Chills; Headache; Temp 100; GI upset; diarrhea; This is a spontaneous report from a contactable physician (patient) reported that a 40-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration on the right arm on 11Jan2021 09:30 at a single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included paracetamol (TYLENOL), ibuprofen and biotin, cyanocobalamin, folic acid (MVI 3). The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899) on 21Dec2020 07:15 on the right arm for COVID-19 immunization. On 11Jan2021 21:30 (reported as 'after 12 hours'), the patient experienced severe body aches, chills, headache and temp 100, then after 48 hours (Jan2021) those symptoms resolved, but had GI upset and diarrhea. The patient underwent lab tests and procedures which included body temperature: 100 (no unit reported) on 11Jan2021. The outcome the events severe body aches, chills, headache and temp 100 was recovered on Jan2021 (reported as after 48 hours those symptoms resolved) while GI upset and diarrhea was recovering. The patient did not received any treatment for the reported events.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Body temperature, Chills, Diarrhoea, Headache
Clinical narrative: Severe body aches; Chills; Headache; Temp 100; GI upset; diarrhea; This is a spontaneous report from a contactable physician (patient) reported that a 40-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration on the right arm on 11Jan2021 09:30 at a single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included paracetamol (TYLENOL), ibuprofen and biotin, cyanocobalamin, folic acid (MVI 3). The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899) on 21Dec2020 07:15 on the right arm for COVID-19 immunization. On 11Jan2021 21:30 (reported as 'after 12 hours'), the patient experienced severe body aches, chills, headache and temp 100, then after 48 hours (Jan2021) those symptoms resolved, but had GI upset and diarrhea. The patient underwent lab tests and procedures which included body temperature: 100 (no unit reported) on 11Jan2021. The outcome the events severe body aches, chills, headache and temp 100 was recovered on Jan2021 (reported as after 48 hours those symptoms resolved) while GI upset and diarrhea was recovering. The patient did not received any treatment for the reported events.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Severe body aches; Chills; Headache; Temp 100; GI upset; diarrhea; This is a spontaneous report from a contactable physician (patient) reported that a 40-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration on the right arm on 11Jan2021 09:30 at a single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included paracetamol (TYLENOL), ibuprofen and biotin, cyanocobalamin, folic acid (MVI 3). The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899) on 21Dec2020 07:15 on the right arm for COVID-19 immunization. On 11Jan2021 21:30 (reported as 'after 12 hours'), the patient experienced severe body aches, chills, headache and temp 100, then after 48 hours (Jan2021) those symptoms resolved, but had GI upset and diarrhea. The patient underwent lab tests and procedures which included body temperature: 100 (no unit reported) on 11Jan2021. The outcome the events severe body aches, chills, headache and temp 100 was recovered on Jan2021 (reported as after 48 hours those symptoms resolved) while GI upset and diarrhea was recovering. The patient did not received any treatment for the reported events.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Hypoaesthesia, Hypoaesthesia oral, Intranasal hypoaesthesia, Paraesthesia
Clinical narrative: had numbness/to her bottom jaw bone/switched between her cheek and jaw and then her nose; face started tingling/from her lower eyelid/switched between her cheek and jaw and then her nose; face started tingling and had numbness/from her lower eyelid; face started tingling and had numbness/affects her lips/and mouth sometimes; face started tingling and had numbness/affects her lips/and mouth sometimes; It is just very annoying/It is irritating; This is a spontaneous report from a contactable nurse (patient). A 34-year-old female patient received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EL3284), via an unspecified route of administration in the left arm on 11Jan2021 12:00 at a single dose for COVID-19 immunization. Medical history included ongoing anxiety since she was 13 years old. The patient's concomitant medications were not reported. The patient received the vaccine on Monday at 12 o'clock. She got it for work. She doesn't have a prescribing doctor. She developed the side effect Tuesday at 2 am. The left side of her face started tingling and had numbness, which is the same side she received the vaccine on. She doesn't have weakness. It is not resolving. It is from her lower eyelid to her bottom jaw bone. When asked if it was improving persisting or worsening, she said it depends. Sometimes it gets worse and affects her lips, and sometimes it is on and off. It won't be completely gone. It switched between her cheek and jaw and then her nose and mouth sometimes. If she bends over, it tingles worse. It is just very annoying. It felt like if she had Novocain on the top and bottom of her mouth. It is irritating. She got it because she doesn't want COVID and she works as a nurse. She does have really bad anxiety. She has nothing else medical. She is just really nervous. It is not going away. She is freaking out. She would like more information. The outcome of the event "It is just very annoying/It is irritating" was unknown, while for the other events was not recovered.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eyelid sensory disorder, Hypoaesthesia, Hypoaesthesia oral, Irritability, Paraesthesia
Clinical narrative: had numbness/to her bottom jaw bone/switched between her cheek and jaw and then her nose; face started tingling/from her lower eyelid/switched between her cheek and jaw and then her nose; face started tingling and had numbness/from her lower eyelid; face started tingling and had numbness/affects her lips/and mouth sometimes; face started tingling and had numbness/affects her lips/and mouth sometimes; It is just very annoying/It is irritating; This is a spontaneous report from a contactable nurse (patient). A 34-year-old female patient received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EL3284), via an unspecified route of administration in the left arm on 11Jan2021 12:00 at a single dose for COVID-19 immunization. Medical history included ongoing anxiety since she was 13 years old. The patient's concomitant medications were not reported. The patient received the vaccine on Monday at 12 o'clock. She got it for work. She doesn't have a prescribing doctor. She developed the side effect Tuesday at 2 am. The left side of her face started tingling and had numbness, which is the same side she received the vaccine on. She doesn't have weakness. It is not resolving. It is from her lower eyelid to her bottom jaw bone. When asked if it was improving persisting or worsening, she said it depends. Sometimes it gets worse and affects her lips, and sometimes it is on and off. It won't be completely gone. It switched between her cheek and jaw and then her nose and mouth sometimes. If she bends over, it tingles worse. It is just very annoying. It felt like if she had Novocain on the top and bottom of her mouth. It is irritating. She got it because she doesn't want COVID and she works as a nurse. She does have really bad anxiety. She has nothing else medical. She is just really nervous. It is not going away. She is freaking out. She would like more information. The outcome of the event "It is just very annoying/It is irritating" was unknown, while for the other events was not recovered.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia oral
Clinical narrative: had numbness/to her bottom jaw bone/switched between her cheek and jaw and then her nose; face started tingling/from her lower eyelid/switched between her cheek and jaw and then her nose; face started tingling and had numbness/from her lower eyelid; face started tingling and had numbness/affects her lips/and mouth sometimes; face started tingling and had numbness/affects her lips/and mouth sometimes; It is just very annoying/It is irritating; This is a spontaneous report from a contactable nurse (patient). A 34-year-old female patient received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EL3284), via an unspecified route of administration in the left arm on 11Jan2021 12:00 at a single dose for COVID-19 immunization. Medical history included ongoing anxiety since she was 13 years old. The patient's concomitant medications were not reported. The patient received the vaccine on Monday at 12 o'clock. She got it for work. She doesn't have a prescribing doctor. She developed the side effect Tuesday at 2 am. The left side of her face started tingling and had numbness, which is the same side she received the vaccine on. She doesn't have weakness. It is not resolving. It is from her lower eyelid to her bottom jaw bone. When asked if it was improving persisting or worsening, she said it depends. Sometimes it gets worse and affects her lips, and sometimes it is on and off. It won't be completely gone. It switched between her cheek and jaw and then her nose and mouth sometimes. If she bends over, it tingles worse. It is just very annoying. It felt like if she had Novocain on the top and bottom of her mouth. It is irritating. She got it because she doesn't want COVID and she works as a nurse. She does have really bad anxiety. She has nothing else medical. She is just really nervous. It is not going away. She is freaking out. She would like more information. The outcome of the event "It is just very annoying/It is irritating" was unknown, while for the other events was not recovered.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Injection site pain, Injection site swelling
Clinical narrative: Extreme fatigue; mild headache; lump and extreme tenderness at injection site; lump and extreme tenderness at injection site; This is a spontaneous report from a contactable other healthcare professional (patient). A 47-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0142), via an unspecified route of administration (left arm) on 08Jan2021 (09:30 AM) at single dose for Covid-19 immunization. The patient received the first dose of Covid-19 vaccine (BNT162B2, lot number: unknown), via an unspecified route of administration left arm on 18Dec2020 (09:30 AM) at single dose for Covid-19 immunization. The patient's medical history was reported as none. There were no concomitant medications. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced extreme fatigue, mild headache, lump and extreme tenderness at injection site on 09Jan2021 (08:00 AM). There was no treatment received for the adverse event. The outcome of events was recovered on an unspecified date. The patient has not been tested for COVID-19 since the vaccination.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Vaccination site mass, Vaccination site pain
Clinical narrative: Extreme fatigue; mild headache; lump and extreme tenderness at injection site; lump and extreme tenderness at injection site; This is a spontaneous report from a contactable other healthcare professional (patient). A 47-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0142), via an unspecified route of administration (left arm) on 08Jan2021 (09:30 AM) at single dose for Covid-19 immunization. The patient received the first dose of Covid-19 vaccine (BNT162B2, lot number: unknown), via an unspecified route of administration left arm on 18Dec2020 (09:30 AM) at single dose for Covid-19 immunization. The patient's medical history was reported as none. There were no concomitant medications. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced extreme fatigue, mild headache, lump and extreme tenderness at injection site on 09Jan2021 (08:00 AM). There was no treatment received for the adverse event. The outcome of events was recovered on an unspecified date. The patient has not been tested for COVID-19 since the vaccination.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Hyperventilation
Clinical narrative: Approximately 3 minutes post injection the patient began hyperventilating 2/2 SOB; Approximately 3 minutes post injection the patient began hyperventilating 2/2 SOB; This is a spontaneous report from a contactable pharmacist. A 38-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot: EL3302), intramuscular on the left arm on 13Jan2021 10:15 at a single dose for COVID-19 immunization. The patient had the vaccine in a hospital. The patient had no other vaccine in four weeks. The patient's medical history and concomitant medications were not reported. The patient was not tested for COVID post vaccination. The patient took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot: EL1284, expiry: unknown) on 23Dec2020 at 10:15, intramuscularly on the left arm for COVID-19 immunization. Approximately 3 minutes post injection (13Jan2021 "10:15"), the patient began hyperventilating "2/2" SOB. RR notified. Patient was placed on 4L O2. The event hyperventilation was not treated. The patient fully recovered on Jan2021.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Hyperventilation, Respiratory rate
Clinical narrative: Approximately 3 minutes post injection the patient began hyperventilating 2/2 SOB; Approximately 3 minutes post injection the patient began hyperventilating 2/2 SOB; This is a spontaneous report from a contactable pharmacist. A 38-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot: EL3302), intramuscular on the left arm on 13Jan2021 10:15 at a single dose for COVID-19 immunization. The patient had the vaccine in a hospital. The patient had no other vaccine in four weeks. The patient's medical history and concomitant medications were not reported. The patient was not tested for COVID post vaccination. The patient took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot: EL1284, expiry: unknown) on 23Dec2020 at 10:15, intramuscularly on the left arm for COVID-19 immunization. Approximately 3 minutes post injection (13Jan2021 "10:15"), the patient began hyperventilating "2/2" SOB. RR notified. Patient was placed on 4L O2. The event hyperventilation was not treated. The patient fully recovered on Jan2021.
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Hypoaesthesia, Injection site pain, Pain
Clinical narrative: Body aches; migraine; numbness in left hand; This is a spontaneous report from a contactable nurse (patient). A 22-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686, expiry date not reported), via an unspecified route of administration in the left arm on 12Jan2021 15:45 at single dose for COVID-19 immunisation. Medical history included iron deficiency anaemia. Concomitant medication included bupropion hydrochloride (WELLBUTRIN). The patient previously took amoxicillin; clavulanic acid (AUGMENTIN) and experienced allergies. The patient previously took first dose of bnt162b2 (lot number: EK5730, expiry date not reported) in the left arm on 23Dec2020 10:00 at single dose for COVID-19 immunisation. On 12Jan2021 16:30, the patient experienced body aches, migraine and numbness in left hand. No treatment was received for the adverse events. Clinical outcome of the events was not recovered.
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Migraine, Pain
Clinical narrative: Body aches; migraine; numbness in left hand; This is a spontaneous report from a contactable nurse (patient). A 22-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686, expiry date not reported), via an unspecified route of administration in the left arm on 12Jan2021 15:45 at single dose for COVID-19 immunisation. Medical history included iron deficiency anaemia. Concomitant medication included bupropion hydrochloride (WELLBUTRIN). The patient previously took amoxicillin; clavulanic acid (AUGMENTIN) and experienced allergies. The patient previously took first dose of bnt162b2 (lot number: EK5730, expiry date not reported) in the left arm on 23Dec2020 10:00 at single dose for COVID-19 immunisation. On 12Jan2021 16:30, the patient experienced body aches, migraine and numbness in left hand. No treatment was received for the adverse events. Clinical outcome of the events was not recovered.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram cerebral, Arteriogram carotid, Blood test, Computerised tomogram head, Hypoaesthesia
Clinical narrative: Employee received covid 19 Pfizer on 12/23/2020.  2 weeks later on 01/06/2021 developed numbness and tingling to toes which progressed to waist and leg weakness by 01/10/2021.  she was admitted to hospital 01-10 to 01-15-2021 and diagnosed with Transverse myelitis due to vaccine.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immunology test, Lumbar puncture, Magnetic resonance imaging brain, Magnetic resonance imaging spinal, Myelitis transverse
Clinical narrative: Employee received covid 19 Pfizer on 12/23/2020.  2 weeks later on 01/06/2021 developed numbness and tingling to toes which progressed to waist and leg weakness by 01/10/2021.  she was admitted to hospital 01-10 to 01-15-2021 and diagnosed with Transverse myelitis due to vaccine.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: Employee received covid 19 Pfizer on 12/23/2020.  2 weeks later on 01/06/2021 developed numbness and tingling to toes which progressed to waist and leg weakness by 01/10/2021.  she was admitted to hospital 01-10 to 01-15-2021 and diagnosed with Transverse myelitis due to vaccine.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiotensin converting enzyme, Blood immunoglobulin G, Blood immunoglobulin M, Borrelia test, Full blood count
Clinical narrative: Employee received covid 19 Pfizer on 12/23/2020.  2 weeks later on 01/06/2021 developed numbness and tingling to toes which progressed to waist and leg weakness by 01/10/2021.  she was admitted to hospital 01-10 to 01-15-2021 and diagnosed with Transverse myelitis due to vaccine.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Gene mutation identification test, Hypoaesthesia, Lumbar puncture, Magnetic resonance imaging, Metabolic function test
Clinical narrative: Employee received covid 19 Pfizer on 12/23/2020.  2 weeks later on 01/06/2021 developed numbness and tingling to toes which progressed to waist and leg weakness by 01/10/2021.  she was admitted to hospital 01-10 to 01-15-2021 and diagnosed with Transverse myelitis due to vaccine.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscular weakness, Myelitis transverse, Paraesthesia
Clinical narrative: Employee received covid 19 Pfizer on 12/23/2020.  2 weeks later on 01/06/2021 developed numbness and tingling to toes which progressed to waist and leg weakness by 01/10/2021.  she was admitted to hospital 01-10 to 01-15-2021 and diagnosed with Transverse myelitis due to vaccine.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Rash erythematous
Clinical narrative: Allergic reaction; Red, blotchy rash on face and chest; Red, blotchy rash on face and chest; This is a spontaneous report from a contactable health professional reported for herself. A 42-year-old non-pregnant female patient received second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EL1283), via an unspecified route of administration in the right arm on 11Jan2021 at a single dose for COVID-19 immunization. The patient was vaccinated in a hospital facility. Medical history included type 2 diabetes, hypothyroidism, and multiple food and med allergies. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient is taking unspecified concomitant medication/s (received within 2 weeks of vaccination). The patient previously received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EL1283) in the right arm on 21Dec2020 05:00 PM at a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 11Jan2021 12:45 PM, the patient experienced allergic reaction of red, blotchy rash on face and chest. The adverse events resulted in emergency room/department or urgent care and doctor or other healthcare professional office/clinic visit. The patient received Benadryl/prednisone as treatments. The outcome of the events was recovering. The events were considered non-serious.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypersensitivity, Rash erythematous, Rash macular
Clinical narrative: Allergic reaction; Red, blotchy rash on face and chest; Red, blotchy rash on face and chest; This is a spontaneous report from a contactable health professional reported for herself. A 42-year-old non-pregnant female patient received second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EL1283), via an unspecified route of administration in the right arm on 11Jan2021 at a single dose for COVID-19 immunization. The patient was vaccinated in a hospital facility. Medical history included type 2 diabetes, hypothyroidism, and multiple food and med allergies. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient is taking unspecified concomitant medication/s (received within 2 weeks of vaccination). The patient previously received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EL1283) in the right arm on 21Dec2020 05:00 PM at a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 11Jan2021 12:45 PM, the patient experienced allergic reaction of red, blotchy rash on face and chest. The adverse events resulted in emergency room/department or urgent care and doctor or other healthcare professional office/clinic visit. The patient received Benadryl/prednisone as treatments. The outcome of the events was recovering. The events were considered non-serious.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: Fever to 100.5; Chills; body aches; headache; This is a spontaneous report from a  contactable physician.  A 31-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:EL3248), via an unspecified route of administration at the left arm on 13Jan2021 11:45 at a single dose for COVID-19 immunization at a hospital.  Medical history was reported as none. The patient does not have any allergies to medications, food, or other products. The patient's concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:EK5730) at the left arm  on 22Dec2020 11:00 AM. The patient experienced fever to 100.5, chills, body aches, and headache on 14Jan2021 10:00. Patient took ibuprofen as a treatment. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for it since the vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient recovered from the events.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Headache, Pain, Pyrexia
Clinical narrative: Fever to 100.5; Chills; body aches; headache; This is a spontaneous report from a  contactable physician.  A 31-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:EL3248), via an unspecified route of administration at the left arm on 13Jan2021 11:45 at a single dose for COVID-19 immunization at a hospital.  Medical history was reported as none. The patient does not have any allergies to medications, food, or other products. The patient's concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:EK5730) at the left arm  on 22Dec2020 11:00 AM. The patient experienced fever to 100.5, chills, body aches, and headache on 14Jan2021 10:00. Patient took ibuprofen as a treatment. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for it since the vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient recovered from the events.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Feeling abnormal, Functional gastrointestinal disorder, Headache
Clinical narrative: At vaccine site, had numbness; tingling on lips and tongue on left side of face; tingling on left side of face; headache/Mild headache; dizzy; exhausted; GI - mild naseau; intestinal discomfort; This is a spontaneous report from a contactable consumer. A 72-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL32216), via an unspecified route of administration on 09Jan2021 10:00 at SINGLE DOSE at arm left for covid-19 immunisation. Medical history included known allergies: yes. Concomitant medications included levothyroxine sodium (SYNTHYROID), lisinopril, fexofenadine hydrochloride (ALLEGRA), progesterone (PROMETRIUM [PROGESTERONE]), and "PULMICO". On 09Jan2021, it was reported that At vaccine site, had numbness, tingling on lips and tongue on left side of face. This has not subsided, sometimes spreading, waxing & waning. Same day - headache, dizzy, exhausted - two days. GI - mild naseau (nausea), intestinal discomfort - on going. Mild headache continuing. The patient did not receive treatment for the events. The outcome of the events was reported as recovering.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral, Nausea, Paraesthesia, Paraesthesia oral
Clinical narrative: At vaccine site, had numbness; tingling on lips and tongue on left side of face; tingling on left side of face; headache/Mild headache; dizzy; exhausted; GI - mild naseau; intestinal discomfort; This is a spontaneous report from a contactable consumer. A 72-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL32216), via an unspecified route of administration on 09Jan2021 10:00 at SINGLE DOSE at arm left for covid-19 immunisation. Medical history included known allergies: yes. Concomitant medications included levothyroxine sodium (SYNTHYROID), lisinopril, fexofenadine hydrochloride (ALLEGRA), progesterone (PROMETRIUM [PROGESTERONE]), and "PULMICO". On 09Jan2021, it was reported that At vaccine site, had numbness, tingling on lips and tongue on left side of face. This has not subsided, sometimes spreading, waxing & waning. Same day - headache, dizzy, exhausted - two days. GI - mild naseau (nausea), intestinal discomfort - on going. Mild headache continuing. The patient did not receive treatment for the events. The outcome of the events was reported as recovering.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Dizziness, Fatigue, Headache, Nausea
Clinical narrative: At vaccine site, had numbness; tingling on lips and tongue on left side of face; tingling on left side of face; headache/Mild headache; dizzy; exhausted; GI - mild naseau; intestinal discomfort; This is a spontaneous report from a contactable consumer. A 72-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL32216), via an unspecified route of administration on 09Jan2021 10:00 at SINGLE DOSE at arm left for covid-19 immunisation. Medical history included known allergies: yes. Concomitant medications included levothyroxine sodium (SYNTHYROID), lisinopril, fexofenadine hydrochloride (ALLEGRA), progesterone (PROMETRIUM [PROGESTERONE]), and "PULMICO". On 09Jan2021, it was reported that At vaccine site, had numbness, tingling on lips and tongue on left side of face. This has not subsided, sometimes spreading, waxing & waning. Same day - headache, dizzy, exhausted - two days. GI - mild naseau (nausea), intestinal discomfort - on going. Mild headache continuing. The patient did not receive treatment for the events. The outcome of the events was reported as recovering.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Paraesthesia oral, Vaccination site hypoaesthesia
Clinical narrative: At vaccine site, had numbness; tingling on lips and tongue on left side of face; tingling on left side of face; headache/Mild headache; dizzy; exhausted; GI - mild naseau; intestinal discomfort; This is a spontaneous report from a contactable consumer. A 72-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL32216), via an unspecified route of administration on 09Jan2021 10:00 at SINGLE DOSE at arm left for covid-19 immunisation. Medical history included known allergies: yes. Concomitant medications included levothyroxine sodium (SYNTHYROID), lisinopril, fexofenadine hydrochloride (ALLEGRA), progesterone (PROMETRIUM [PROGESTERONE]), and "PULMICO". On 09Jan2021, it was reported that At vaccine site, had numbness, tingling on lips and tongue on left side of face. This has not subsided, sometimes spreading, waxing & waning. Same day - headache, dizzy, exhausted - two days. GI - mild naseau (nausea), intestinal discomfort - on going. Mild headache continuing. The patient did not receive treatment for the events. The outcome of the events was reported as recovering.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Limb discomfort, Pruritus, Rash erythematous, Rash papular
Clinical narrative: The next day when I woke up on 12/30/2020 I woke up with a rash all over my body but worst part was stomach. It was bumpy & itchy. I also had chills for about 1 day. I went to urgent care on 01/04/2020 & the doctor from said it could be pityriasis osis.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Pityriasis, Rash, Rash papular, Rash pruritic
Clinical narrative: The next day when I woke up on 12/30/2020 I woke up with a rash all over my body but worst part was stomach. It was bumpy & itchy. I also had chills for about 1 day. I went to urgent care on 01/04/2020 & the doctor from said it could be pityriasis osis.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature increased, Chills, Cold sweat, Gait disturbance, Injection site pain
Clinical narrative: Woke up at 01:00 with severe body aches; was hard to walk or move; cold sweats; Chills; fever of 100.3 F; This is a spontaneous report from a contactable nurse reported for herself. A 42-years-old female patient received second dose of bnt162b2 (BNT162B2), intramuscular on 14Jan2021 10:00 at single dose on left arm for covid-19 immunisation. The patient medical history was not reported. The patient had no allergies to medications, food, or other products. Concomitant medication included lisdexamfetamine mesilate (VYVANSE), clonazepam (KLONOPIN), quetiapine fumarate (SEROQUEL), aspirin [acetylsalicylic acid] (ASPIRIN). The patient received first dose of COVID 19 for covid-19 immunisation at 42-years-old, lot unknown=False, administration date=on 24Dec2020 09:00 AM, administrator route=Intramuscular, vaccine location=Left arm. The patient experienced woke up at 01:00 with severe body aches, was hard to walk or move, cold sweats, chills, fever of 100.3 f on 15Jan2021 13:00. Lab data included body temperature 100.3 f on 15Jan2021 13:00. The event outcome was recovering. No treatment was received for the adverse event. The events were reported as non-serious. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  Information on the lot/batch number has been requested.